Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 12 studies | 75% ± 20% | |
GABAergic neuron | 11 studies | 67% ± 26% | |
oligodendrocyte precursor cell | 11 studies | 39% ± 13% | |
interneuron | 7 studies | 64% ± 24% | |
neuron | 6 studies | 51% ± 15% | |
endothelial cell | 4 studies | 58% ± 16% | |
astrocyte | 4 studies | 33% ± 25% | |
microglial cell | 4 studies | 40% ± 20% | |
retinal ganglion cell | 4 studies | 25% ± 6% | |
amacrine cell | 4 studies | 18% ± 2% | |
GABAergic interneuron | 3 studies | 85% ± 9% | |
granule cell | 3 studies | 61% ± 29% | |
GABAergic amacrine cell | 3 studies | 24% ± 8% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 15 studies | 47% ± 25% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 95% | 3366.74 | 2505 / 2642 | 47% | 2.45 | 330 / 705 |
intestine | 4% | 8.65 | 41 / 966 | 17% | 0.29 | 91 / 527 |
stomach | 4% | 5.32 | 13 / 359 | 15% | 0.29 | 44 / 286 |
breast | 15% | 29.66 | 67 / 459 | 1% | 0.01 | 6 / 1118 |
adipose | 10% | 19.96 | 122 / 1204 | 0% | 0 | 0 / 0 |
kidney | 6% | 14.33 | 5 / 89 | 1% | 0.01 | 10 / 901 |
bladder | 0% | 0 | 0 / 21 | 6% | 0.18 | 29 / 504 |
esophagus | 1% | 2.39 | 18 / 1445 | 3% | 0.04 | 5 / 183 |
ovary | 2% | 4.61 | 4 / 180 | 1% | 0.01 | 4 / 430 |
skin | 0% | 0.49 | 4 / 1809 | 3% | 0.04 | 13 / 472 |
uterus | 0% | 0 | 0 / 170 | 2% | 0.03 | 9 / 459 |
lung | 1% | 0.99 | 4 / 578 | 1% | 0.01 | 11 / 1155 |
liver | 1% | 1.62 | 3 / 226 | 0% | 0.00 | 1 / 406 |
eye | 0% | 0 | 0 / 0 | 1% | 0.02 | 1 / 80 |
prostate | 1% | 2.48 | 3 / 245 | 0% | 0 | 0 / 502 |
adrenal gland | 0% | 0.66 | 1 / 258 | 0% | 0.01 | 1 / 230 |
blood vessel | 1% | 1.40 | 10 / 1335 | 0% | 0 | 0 / 0 |
pancreas | 0% | 0 | 0 / 328 | 1% | 0.02 | 1 / 178 |
thymus | 0% | 0.41 | 2 / 653 | 0% | 0 | 0 / 605 |
heart | 0% | 0.17 | 1 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0097553 | Biological process | calcium ion transmembrane import into cytosol |
GO_0019722 | Biological process | calcium-mediated signaling |
GO_0007611 | Biological process | learning or memory |
GO_0060079 | Biological process | excitatory postsynaptic potential |
GO_0035235 | Biological process | ionotropic glutamate receptor signaling pathway |
GO_0098976 | Biological process | excitatory chemical synaptic transmission |
GO_0060291 | Biological process | long-term synaptic potentiation |
GO_0045471 | Biological process | response to ethanol |
GO_2000463 | Biological process | positive regulation of excitatory postsynaptic potential |
GO_0099505 | Biological process | regulation of presynaptic membrane potential |
GO_0048167 | Biological process | regulation of synaptic plasticity |
GO_1904062 | Biological process | regulation of monoatomic cation transmembrane transport |
GO_0048168 | Biological process | regulation of neuronal synaptic plasticity |
GO_2001056 | Biological process | positive regulation of cysteine-type endopeptidase activity |
GO_0007268 | Biological process | chemical synaptic transmission |
GO_0098655 | Biological process | monoatomic cation transmembrane transport |
GO_0051290 | Biological process | protein heterotetramerization |
GO_0007420 | Biological process | brain development |
GO_0051968 | Biological process | positive regulation of synaptic transmission, glutamatergic |
GO_1902951 | Biological process | negative regulation of dendritic spine maintenance |
GO_0007215 | Biological process | glutamate receptor signaling pathway |
GO_0035249 | Biological process | synaptic transmission, glutamatergic |
GO_0098839 | Cellular component | postsynaptic density membrane |
GO_0005856 | Cellular component | cytoskeleton |
GO_0005886 | Cellular component | plasma membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0097060 | Cellular component | synaptic membrane |
GO_0005764 | Cellular component | lysosome |
GO_0043005 | Cellular component | neuron projection |
GO_0009986 | Cellular component | cell surface |
GO_0014069 | Cellular component | postsynaptic density |
GO_0005770 | Cellular component | late endosome |
GO_0005737 | Cellular component | cytoplasm |
GO_0045211 | Cellular component | postsynaptic membrane |
GO_0017146 | Cellular component | NMDA selective glutamate receptor complex |
GO_1904315 | Molecular function | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential |
GO_0004972 | Molecular function | NMDA glutamate receptor activity |
GO_0001540 | Molecular function | amyloid-beta binding |
GO_0016595 | Molecular function | glutamate binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0016594 | Molecular function | glycine binding |
GO_0099507 | Molecular function | ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential |
GO_0022849 | Molecular function | glutamate-gated calcium ion channel activity |
GO_0005515 | Molecular function | protein binding |
Gene name | GRIN2B |
Protein name | Glutamate receptor Glutamate receptor ionotropic, NMDA 2B (GluN2B) (Glutamate [NMDA] receptor subunit epsilon-2) (N-methyl D-aspartate receptor subtype 2B) (NMDAR2B) (NR2B) (N-methyl-D-aspartate receptor subunit 3) (NR3) (hNR3) Glutamate ionotropic receptor NMDA type subunit 2B |
Synonyms | NMDAR2B hCG_1811072 |
Description | FUNCTION: Component of NMDA receptor complexes that function as heterotetrameric, ligand-gated ion channels with high calcium permeability and voltage-dependent sensitivity to magnesium. Channel activation requires binding of the neurotransmitter glutamate to the epsilon subunit, glycine binding to the zeta subunit, plus membrane depolarization to eliminate channel inhibition by Mg(2+) . Sensitivity to glutamate and channel kinetics depend on the subunit composition . In concert with DAPK1 at extrasynaptic sites, acts as a central mediator for stroke damage. Its phosphorylation at Ser-1303 by DAPK1 enhances synaptic NMDA receptor channel activity inducing injurious Ca2+ influx through them, resulting in an irreversible neuronal death. Contributes to neural pattern formation in the developing brain. Plays a role in long-term depression (LTD) of hippocampus membrane currents and in synaptic plasticity (By similarity). . FUNCTION: Receptor for glutamate that functions as a ligand-gated ion channel in the central nervous system and plays an important role in excitatory synaptic transmission. L-glutamate acts as an excitatory neurotransmitter at many synapses in the central nervous system. . |
Accessions | A0A8D9PHB2 A0A0D9SFK0 ENST00000630791.2 ENST00000609686.4 Q13224 ENST00000627535.2 ENST00000637214.1 A0A0D9SFA0 A0A1B0GU78 |